Ru-Based NSAIDs as Potential Anticancer Therapeutics.
Silvia Bordoni, Magda Monari, Carla Boga, Federico Moro, Giacomo Drius · Molecules (Basel, Switzerland) · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In this context, five well-known non-steroidal anti-inflammatory drugs (NSAIDs) were employed to substitute both PPh3 and hydride ligands in [Ru(H)2(CO)(PPh3)3] (1), thereby selectively affording neutral κ2-(O,O)-chelate complexes in satisfactory yields via molecular hydrogen release. The authors concluded that the synthesized compounds contain both carboxylic groups from NSAIDs and phosphine ligands, therefore imparting amphiphilic features to the Ru core and enhancing its ability to be delivered to cancer targets. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in HeLa Cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). In this context, five well-known non-steroidal anti-inflammatory drugs (NSAIDs) were employed to substitute both PPh3 and hydride ligands in [Ru(H)2(CO)(PPh3)3] (1), thereby selectively affording neutral κ2-(O,O)-chelate complexes in satisfactory yields via molecular hydrogen release.
What the Researchers Studied
The researchers studied HeLa Cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). The study used a in vitro cell-culture laboratory experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
The solid was filtered, washed with hexane, and subsequently with H₂O (10 mL aliquots × 3 times). All non-hydrogen atoms were assigned to anisotropic displacement parameters. Most of the hydrogen atoms were located in the Fourier map, placed in idealized positions, and included as riding with constrained isotropic displacement parameters for the aromatic and methyl protons and refined as riding with Uiso(H) = 1.2Ueq(C) or Uiso(H) = 1.3Ueq(C)methyl. In this context, five well-known non-steroidal anti-inflammatory drugs (NSAIDs) were employed to substitute both PPh3 and hydride ligands in [Ru(H)2(CO)(PPh3)3] (1), thereby selectively affording neutral κ2-(O,O)-chelate complexes in satisfactory yields via molecular hydrogen release. The authors concluded that the synthesized compounds contain both carboxylic groups from NSAIDs and phosphine ligands, therefore imparting amphiphilic features to the Ru core and enhancing its ability to be delivered to cancer targets.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The research population or model was HeLa Cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). The study used a in vitro cell-culture laboratory experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.